uCyt+/ImmunoCyt™ in the detection of recurrent urothelial carcinoma : An update on 1991 analyses (pages 60–65)
Christine Mian, Klaus Maier, Evi Comploj, Michele Lodde, Lucas Berner, Lukas Lusuardi, Salvatore Palermo, Fabio Vittadello and Armin Pycha
Version of Record online: 12 JAN 2006 | DOI: 10.1002/cncr.21712
The clinical value of the uCyt+/ImmunoCyt™ test was evaluated as a noninvasive tool for the detection of recurrent urothelial carcinoma (UC). Used as a noninvasive tool, cytology combined with the uCyt+/ImmunoCyt test may reduce the morbidity and cost of follow-up in patients who have a low risk of recurrent UC, although additional studies will be necessary to establish and compare the morbidity and cost of each method.